About: Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2012

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2012 (uk) artículu científicu espublizáu n'ochobre de 2012 (ast) scientific article published on 01 October 2012 (en) գիտական հոդված հրատարակված 2012 թվականի հոկտեմբերի 1-ին (hy)
publication date	wds:Q85009916-134516E6-D400-48D1-A47C-E8E10D40F0BE
publication date	2012-10-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q85009916-933295C9-CD1B-4DAA-BFE3-ABE66C37106C wds:Q85009916-9B7BDBFA-8765-4253-A91A-9BDCBBBD1095 wds:Q85009916-B442E320-ECF1-4C9F-9669-FE0199E79DD3
author name string	O Rosmorduc P Rougier C Verslype
rdfs:label	Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up (en) Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up (nl)
skos:prefLabel	Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up (en) Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up (nl)
name	Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up (en) Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up (nl)
author	wds:Q85009916-17C17B0A-424F-4BE6-A641-60A8125DE235
author	ESMO Guidelines Working Group
title	wds:Q85009916-19CD7B73-2C0D-4EA6-BE14-F2613C7B458F
title	Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up (en)
page(s)	wds:Q85009916-E9BCF9FE-EFAC-4B29-80E5-87A06C738DAD
page(s)	vii41-8
instance of	wds:Q85009916-FB301D2B-1C75-4E3E-A447-C4CD254E1526
instance of	scholarly article
main subject	wds:Q85009916-1E0D44FE-5241-4569-A954-463742806411
main subject	hepatocellular carcinoma
PubMed ID	wds:Q85009916-1672DBD7-51E6-4F88-AD38-390166FE7FAC
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22997453
PubMed ID	22997453
published in	wds:Q85009916-0CF07C53-F635-44F2-B1F5-49AF546EF407
published in	Annals of Oncology
volume	wds:Q85009916-EAACCFAA-83D8-48EA-9795-738D5834B90A
volume	23 Suppl 7
DOI	wds:Q85009916-F9E4D9DA-1427-4A09-ACEA-FFB906009709
DOI	http://dx.doi.org/10.1093/ANNONC/MDS225
DOI	10.1093/ANNONC/MDS225
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q85009916
is cites work of	The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design Multi-omics in prognosis of hepatocellular carcinoma Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma Biopsy for liver cancer: how to balance research needs with evidence-based clinical practice Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial Contrast-enhanced ultrasonography for the diagnosis of small hepatocellular carcinoma: a meta-analysis and meta-regression analysis Treatment algorithms for managing hepatocellular carcinoma Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016 Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma Treatment of intermediate-stage hepatocellular carcinoma Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry. Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma. Hepatocellular Carcinoma: Basic and Transitional Research Image-guided ablation of primary liver and renal tumours Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition Liver cancer: Approaching a personalized care Sorafenib: from literature to clinical practice Role of local ablative therapy for hepatocellular carcinoma Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma? Hepatocellular carcinoma: a review Clinically Meaningful Use of Blood Tumor Markers in Oncology. Sorafenib: A Review in Hepatocellular Carcinoma Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors? Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events. Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment. Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3 The impact of perioperative allogeneic blood transfusion on prognosis of hepatocellular carcinoma after radical hepatectomy: A systematic review and meta-analysis of cohort studies Implication of the Hedgehog pathway in hepatocellular carcinoma. Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review. Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. Current topics in the surgical treatments for hepatocellular carcinoma. Upregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival. Identification of Biologically Effective Dose-Volumetric Parameters That Predict Radiation-Induced Hepatic Toxicity in Patients Treated With Helical Tomotherapy for Unresectable Locally Advanced Hepatocellular Carcinoma Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study. Investigating the Accuracy of Ultrasound-Ultrasound Fusion Imaging for Evaluating the Ablation Effect via Special Phantom-Simulated Liver Tumors Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice. A systematic review of publications on charged particle therapy for hepatocellular carcinoma.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software